A recent study showed that circCRIM1 prevented its inhibitory effect on the target gene FOXQ1 through competitive binding with miR-422a, promoted the metastasis of nasopharyngeal carcinoma, and developed resistance to docetaxel chemotherapy (Hong et al., 2020). The gene discussed is FOXQ1; the disease is nasopharyngeal carcinoma.